Nuwellis, Inc. (NUWE)
NASDAQ: NUWE · Real-Time Price · USD
3.250
+0.220 (7.26%)
At close: Oct 24, 2025, 4:00 PM EDT
3.142
-0.108 (-3.31%)
After-hours: Oct 24, 2025, 7:10 PM EDT
Nuwellis Market Cap
Nuwellis has a market cap or net worth of $2.93 million as of October 24, 2025. Its market cap has decreased by -1.17% in one year.
Market Cap
2.93M
Enterprise Value
-1.08M
1-Year Change
-1.17%
Ranking
Category
Stock Price
$3.25
Market Cap Chart
Since December 6, 2019, Nuwellis's market cap has decreased from $3.25M to $2.93M, a decrease of -9.60%. That is a compound annual growth rate of -1.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 2.93M | -27.92% |
| Dec 31, 2024 | 4.07M | 114.71% |
| Dec 29, 2023 | 1.90M | -65.92% |
| Dec 30, 2022 | 5.56M | -53.25% |
| Dec 31, 2021 | 11.90M | -35.49% |
| Dec 31, 2020 | 18.44M | 385.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 6, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.04B |
| Johnson & Johnson | 457.77B |
| AbbVie | 402.76B |
| UnitedHealth Group | 328.31B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 220.78B |